Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06304233
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2023-12-11
Brief Title:
The Protein Disrupted in Schizophrenia 1 DISC1 as a Novel Biomarker for Cardiac Disease
Sponsor:
Norwegian University of Science and Technology
Organization:
Norwegian University of Science and Technology
Study Overview
Official Title:
The Protein Disrupted in Schizophrenia 1 DISC1 as a Novel Biomarker for Cardiac Disease - The Link Between DISC1 and Cardiac Function in Patients With Schizophrenia
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the association between DISC1 RNA expression levels and cardiac function in patients with schizophrenia
Detailed Description:
Potential participants interested in the study will be screened for eligibility Those who meet the eligibility criteria will be informed about the study the expected investigations and its potential risks All participants giving written informed consent will be enrolled into the study Participants will be interviewed given questionnaires have blood andor skin samples and clinical parameters taken Cardiac function parameters will be measured using electrocardiography echocardiography and magnetic resonance imaging
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None